Pharmaceutical Companies and Patient Care – The Mixed Effects Model

Gururangan’s project broadens the data applied to a critical question – how do pharmaceutical companies influence healthcare at the level of patient health and access to health services? In answering this question, he explored article databases from a variety of disciplines and print resources located in the Gardner Stacks, and the libraries at Haas School of Business and the School of Public Health and used them to compare the positive and negative outcomes produced by treatment innovation and lobbying capability. Prof. Ross stated that “his ability to research and synthesize information across different disciplines, using starkly different methodologies and various types of data makes his paper stand out amongst his peers.

Pharmaceutical Companies and Patient Care – The Mixed Effects Model

Gururangan’s project broadens the data applied to a critical question – how do pharmaceutical companies influence healthcare at the level of patient health and access to health services? In answering this question, he explored article databases from a variety of disciplines and print resources located in the Gardner Stacks, and the libraries at Haas School of Business and the School of Public Health and used them to compare the positive and negative outcomes produced by treatment innovation and lobbying capability. Prof. Ross stated that “his ability to research and synthesize information across different disciplines, using starkly different methodologies and various types of data makes his paper stand out amongst his peers.